ArticleClinical case reports2022

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab.

Brendan K Bowens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.